ACADIAN ASSET MANAGEMENT LLC - KINTARA THERAPEUTICS INC ownership

KINTARA THERAPEUTICS INC's ticker is and the CUSIP is 49720K200. A total of 11 filers reported holding KINTARA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of KINTARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$03500.0%0.00%
Q1 2024$0
-100.0%
350
-99.7%
0.00%
Q4 2023$21
-16.0%
127,777
+1871.9%
0.00%
Q3 2023$250.0%6,4800.0%0.00%
Q2 2023$25
+13.6%
6,4800.0%0.00%
Q1 2023$22
-50.0%
6,480
+0.0%
0.00%
Q4 2022$446,4780.00%
Other shareholders
KINTARA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
FMR LLC 58$2140.00%
WELLS FARGO & COMPANY/MN 11$390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 2,139$7,5480.00%
OSAIC HOLDINGS, INC. 981$3,4480.00%
GEODE CAPITAL MANAGEMENT, LLC 14,036$51,6520.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,662$39,2360.00%
Tower Research Capital LLC (TRC) 1,791$60.00%
MORGAN STANLEY 3,346$11,8080.00%
ACADIAN ASSET MANAGEMENT LLC 6,480$220.00%
View complete list of KINTARA THERAPEUTICS INC shareholders